E-DRUG: Pharmaceutical Pricing and Reimbursement series
----------------------------------------------------------------------------
Dear Colleagues,
Happy new year!
I want to share with you the closing article of the special series
"Pharmaceutical Pricing and Reimbursement Policies" at the Brazilian
Journal of Hospital Pharmacy and Health Services (RBFHSS) where I had the
honour to be the guest editor.
Besides this article, the series included an editorial, a perspective on
the Pharmaceutical Pricing and Reimbursement Policies (PPRI) network and
eight country case studies, namely Austria, Brazil, Greece, Canada, Italy,
the United Kingdom, Portugal and the United States.
A huge thanks to the authors' valuable contributions, the guest editorial
committee, and the journal's team, for making the series possible. In
Brazil, "we look forward to the perspective of a transition, hoping for the
best, and pleading for the strengthening of pharmaceutical regulation,
pricing, and reimbursement policies, addressing market failures, as well as
improving the sustainability and access to medicines and other health
technologies".
In this sense, we can look at the experiences in the case studies of the
series as examples of benchmarking and best practice, opportunities for
increasing collaboration, and sources of inspiration.
https://lnkd.in/ddxjDNwC
All the articles in the series can be accessed here:
https://lnkd.in/dtyB-Dr4
All the best,
Adriana Ivama Brummell
Health Regulatory Expert, Brazilian Health Regulatory Agency (Anvisa)
Visiting Fellow, Department of Health Policies, London School of Economics
and Political Science (LSE)
<adriana.ivama@gmail.com>